UNSPSC 51172173: Fenpiprane hydrochloride

This classification denotes an anticholinergic agent with the molecular formula C20H25N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 684N1BF96B, chemically known as 3-piperidino-1,1-diphenylpropane hydrochloride but more generally known as fenpiprane hydrochloride, which bears US NIH Compound Identifier 197784. Most nations, for tariff and trade purposes, schedule fenpiprane hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, FENPIPRANE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Fenpiprane hydrochloride bears US NLM NCI C65667. SMILES: C1CCC(CC1)C(CCN2CCCCC2)C3CCCCC3.CL.

UNSPSC 51172173 Fenpiprane hydrochloride is a Commodity code that represents pharmaceutical active ingredients, but recent state and local procurement activity under this code does not reflect pharmaceutical procurement. Instead, Collin County Community Supervision and Corrections Department (CSCD) in Texas has tagged its offender specimen collection and drug testing services RFP under this code — a mismatch indicating the code shows little relevant recent activity in the state and local space aligned with its nominal pharmaceutical scope. The single recent opportunity on record involves staffing two testing collection sites in Plano and McKinney, operating an Interactive Voice Response system for randomized testing notifications, and conducting immunoassay screening with LC/MS/MS or GC/MS confirmation across approximately 25,031 annual tests (comprising five-panel and six-panel drug screens plus ancillary testing).

Collin County CSCD issued RFP 2026-327 for offender specimen collection and drug testing services with an estimated contract value of $600,000, a two-year term commencing September 1, 2026, and three optional one-year renewal periods not to exceed five years total. The county requires SAMHSA, Texas Department of Public Safety, or CAP lab certification, and pricing must be submitted on a per-test basis across three service models (screening only, confirmation after screening, and screening with automatic confirmation of positives). The response deadline was July 23, 2026, and the anticipated award date was August 10, 2026. Evaluation criteria weight vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 additional points. The county reserves the right to award in whole or in part to multiple vendors.